In the intricate landscape of neuroscience, the lateral habenula (LHb) stands out as a critical structure in understanding depression. This...
Read More
Reflections from the Office
Ketamine and the Future of Mental Health: Insights from the Oxford International Conference
The Oxford Ketamine International Conference in March 2024 brought together leading experts and researchers from around the world to explore...
Read More
Even More on Brain Zaps
People outside the mainstream medical establishment continue to show interest in the phenomenon of brain zaps, while academia remains ...
Read More
The Risks of Take-Home Ketamine: A Cautionary Perspective
Ketamine, an NMDA receptor antagonist, has shown promise in the treatment of various psychiatric disorders, including depression and PTSD. Its...
Read More
Exploring Ketamine Therapy Risks in Light of Matthew Perry’s Untimely Passing
Matthew Perry, celebrated for his iconic role on "Friends," tragically passed away on October 28, 2023, after being found unresponsive...
Read More
A new oral medication for Postpartum Depression
The first oral pill approved by the US Food and Drug Administration (FDA) to treat postpartum depression, called Zurzuvae, developed...
Read More